Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.

Developments in biologicals

Volumn 112, Issue , 2003, Pages 37-53

  Wagner, C L ^a   Schantz, A ^a   Barnathan, E ^a   Olson, A ^a   Mascelli, M A ^a   Ford, J ^a   Damaraju, L ^a   Schaible, T ^a   Maini, R N ^a   Tcheng, J E ^a  

^a CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; THROMBOCYTE COUNT;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; CLINICAL TRIALS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PLATELET COUNT;

EID: 0042305160     PISSN: 14246074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)